MRO, a prominent player in healthcare data management, has acquired Clinetic, a recruitment management platform aimed at improving clinical trial patient recruitment. While the financial terms of the acquisition remain undisclosed, this strategic move is set to enhance MRO’s commitment to utilizing smarter data solutions.
Integration of AI-Driven Solutions
The acquisition brings Clinetic’s advanced AI-driven software into MRO’s portfolio. This technology leverages real-time Electronic Health Record (EHR) data, allowing healthcare organizations and life sciences companies to identify, screen, and enroll patients for clinical trials with increased efficiency and accuracy.
Clinetic’s software addresses significant resource and technology challenges faced by hospitals and research institutions. By integrating directly with provider EHR systems through secure, behind-the-firewall connectors, the software provides seamless access to comprehensive historical and clinical data. This data is crucial for fulfilling the specific requirements of various clinical trial protocols.
Research teams can now utilize this real-time data layer to effectively identify eligible patients across diverse therapeutic areas, build more precise participant cohorts, and plan studies with enhanced confidence.
Commitment to Transforming Clinical Data
Tom Kaminski, CEO of Clinetic, expressed enthusiasm about the acquisition, stating, “Clinetic has strong roots in healthcare, already evaluating the data of more than 15 million patients across the US. Joining MRO was a natural fit, considering our joint focus on transforming unstructured clinical data into actionable data sets and unwavering commitment to our hospital partners and the communities they serve.”
This acquisition marks a significant step in MRO’s ongoing effort to position itself as the leading source for smarter data solutions in the healthcare sector. By combining Clinetic’s innovative technology with its existing resources, MRO aims to streamline patient recruitment processes and ultimately enhance the efficiency of clinical trials.
As the demand for clinical trials continues to grow, the integration of AI and EHR systems is becoming increasingly vital. MRO’s acquisition of Clinetic is indicative of a broader trend towards leveraging technology to improve patient outcomes and accelerate the research process.
